For 21 years, I have led an overnight backpacking excursion to a different wild spot in Pennsylvania on a cold, preferably snowy, winter weekend.
We donât do it to prove our mettle, but to immerse ourselves in a landscape of sights, sounds and light experienced at no other time of year. Itâs also an antidote to seasonal affective disorder.
Nearly each year, several people among us are experiencing winter hiking and camping for the first time. Sometimes overcoming a lifetime of trepidation, they are thrilled to learn that being outdoors when itâs freezing can be quite comfortable as long as they are wearing appropriate layers of clothing and bring the right gear.
In order to avoid the occurrence of such effects, the Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV) recommended guidance values for maximum THC levels in various food groups in 2000.
A new, highly accurate COVID-19 test is being trialled at the Royal Lancaster Infirmary. Virus Hunter 6 (VH6) has been developed by Lancaster University.
Forest officials said that the tiger was a male, aged between five to six-years. Initial investigations suggest that it died of electrocution as electric wires were found in the field on Monday.Divi
(2)
- Vaccine Candidate Previously Demonstrated Antibodies and T-cell Response in Mouse Models
- Clinical Trial to Serve as Initial Validation of LinearDNA Platform in Large Mammals with Potential Advantages in Manufacturing, Storage, and Distribution over Other Vaccines Applied DNA Sciences, Inc. (NASDAQ: APDN) (the Company ), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. ( Evvivax ), today announced the initiation of Phase I of a two-phase clinical trial to evaluate a LinearDNA COVID-19 vaccine candidate for the feline veterinary market. The goal of the trial is to evaluate the vaccine candidate as a strategy for the prevention of SARS-CoV-2, the virus that causes COVID-19, in feline companions of humans that may mitigate the animals as a potential reservoir for infections in humans. If successful, the clinical trial will also serve as an important initial validation of LinearDNA, Applied DNA s la